Clinical Trial Update: ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling [Phase 2]

View source ↗

Summary

Phase 2 Danish nationwide trial (ProTarget) uses genomic profiling to guide targeted cancer treatment; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Ulrik Lassen | Conditions: Cancer, Tumors | Phase 2 | Status: RECRUITING